Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Osório FL, Sanches R, Dos Santos RG, Tófoli LF, de Oliveira Silveira G, Yonamine M, Riba J, Santos FR, Silva-Junior AA, Alchieri JC, Galvão-Coelho NL, Lobão-Soares B, Hallak JEC, Arcoverde E, Maia-de-Oliveira JP, Araújo DB. Palhano-Fontes F, et al. Among authors: arcoverde e. Psychol Med. 2019 Mar;49(4):655-663. doi: 10.1017/S0033291718001356. Epub 2018 Jun 15. Psychol Med. 2019. PMID: 29903051 Free PMC article. Clinical Trial.
Ayahuasca for the Treatment of Depression.
Palhano-Fontes F, Soares BL, Galvão-Coelho NL, Arcoverde E, Araujo DB. Palhano-Fontes F, et al. Among authors: arcoverde e. Curr Top Behav Neurosci. 2022;56:113-124. doi: 10.1007/7854_2021_277. Curr Top Behav Neurosci. 2022. PMID: 34761362
Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.
da Costa Gonçalves KT, de Tavares VDO, de Morais Barros ML, de Brito AJC, Cavalcanti-Ribeiro P, Palhano-Fontes F, Falchi-Carvalho M, Arcoverde E, Dos Santos RG, Hallak JEC, de Araujo DB, Galvão-Coelho NL. da Costa Gonçalves KT, et al. Among authors: arcoverde e. Eur Arch Psychiatry Clin Neurosci. 2024 Oct 28. doi: 10.1007/s00406-024-01925-6. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39467856
Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.
Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT, de Almeida VRN, Barbosa DC, de Araújo Ferreira MA, Bolcont R, De Souza LCAM, Santos NC, Lopes EITC, de Medeiros Lima NB, de Brito AJC, Falchi-Carvalho M, Arcoverde E, Araujo D, Galvão-Coelho NL. Palhano-Fontes F, et al. Among authors: arcoverde e. J Affect Disord. 2025 Jan 15;369:155-163. doi: 10.1016/j.jad.2024.09.141. Epub 2024 Sep 26. J Affect Disord. 2025. PMID: 39341294 Clinical Trial.
Effectiveness of an affect-adjusted, supervised, multimodal, online and home-based exercise group protocol for major depression: A randomized controlled trial.
Tavares VDO, Schuch FB, de Sousa GM, Hallgren M, Oliveira Neto L, Cabral DAR, Nóbrega de Almeida R, Barbosa DC, de Almeida VRN, Tinoco H, Lira RA, Hallak JE, Arcoverde E, Cuthbert C, Patten S, Galvão-Coelho NL. Tavares VDO, et al. Among authors: arcoverde e. Psychol Sport Exerc. 2025 Jan;76:102729. doi: 10.1016/j.psychsport.2024.102729. Epub 2024 Sep 18. Psychol Sport Exerc. 2025. PMID: 39299665 Clinical Trial.
Self-Reported Mood and Lifestyle-Related Physical Activity of Young Adults With Major Depressive Disorder.
Tavares VDO, de Sousa GM, Schuch FB, Campanelli S, Meyer J, de Almeida RN, Agrícola PMD, Alves L, Gurgel ML, Gonçalves KTDC, Patten S, Sarris J, Barbalho W, Arcoverde EN, Galvão-Coelho NL. Tavares VDO, et al. Among authors: arcoverde en. Percept Mot Skills. 2024 Apr;131(2):489-513. doi: 10.1177/00315125241226997. Epub 2024 Jan 17. Percept Mot Skills. 2024. PMID: 38231015
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F. Falchi-Carvalho M, et al. Among authors: arcoverde e. Eur Neuropsychopharmacol. 2024 Mar;80:27-35. doi: 10.1016/j.euroneuro.2023.12.006. Epub 2023 Dec 22. Eur Neuropsychopharmacol. 2024. PMID: 38141403 Clinical Trial.